Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

Current Pathological and Laboratory Considerations in the Diagnosis of Disseminated Intravascular Coagulation

  • Toh, Cheng-Hock (Institute of Infection and Global Health, University of Liverpool) ;
  • Alhamdi, Yasir (Institute of Infection and Global Health, University of Liverpool) ;
  • Abrams, Simon T. (Institute of Infection and Global Health, University of Liverpool)
  • Received : 2016.05.04
  • Accepted : 2016.07.22
  • Published : 2016.11.01
⟨ Previous Next ⟩

Abstract

Systemically sustained thrombin generation in vivo is the hallmark of disseminated intravascular coagulation (DIC). Typically, this is in response to a progressing disease state that is associated with significant cellular injury. The etiology could be infectious or noninfectious, with the main pathophysiological mechanisms involving cross-activation among coagulation, innate immunity, and inflammatory responses. This leads to consumption of both pro- and anticoagulant factors as well as endothelial dysfunction and disrupted homeostasis at the blood vessel wall interface. In addition to the release of tissue plasminogen activator (tPA) and soluble thrombomodulin (sTM) following cellular activation and damage, respectively, there is the release of damage-associated molecular patterns (DAMPs) such as extracellular histones and cell-free DNA. Extracellular histones are increasingly recognized as significantly pathogenic in critical illnesses through direct cell toxicity, the promotion of thrombin generation, and the induction of neutrophil extracellular trap (NET) formation. Clinically, high circulating levels of histones and histone-DNA complexes are associated with multiorgan failure, DIC, and adverse patient outcomes. Their measurements as well as that of other DAMPs and molecular markers of thrombin generation are not yet applicable in the routine diagnostic laboratory. To provide a practical diagnostic tool for acute DIC, a composite scoring system using rapidly available coagulation tests is recommended by the International Society on Thrombosis and Haemostasis. Its usefulness and limitations are discussed alongside the advances and unanswered questions in DIC pathogenesis.

Keywords

References

  1. Crawley JT, Zanardelli S, Chion CK, Lane DA. The central role of thrombin in hemostasis. J Thromb Haemost 2007;5(S1):95-101. https://doi.org/10.1111/j.1538-7836.2007.02500.x
  2. Taylor FB Jr, Wada H, Kinasewitz G. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC. Crit Care Med 2000;28(9S): S12-9. https://doi.org/10.1097/00003246-200009001-00004
  3. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M; Scientific Subcommittee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001;86:1327-30. https://doi.org/10.1055/s-0037-1616068
  4. Bakhtiari K, Meijers JC, de Jonge E, Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004;32: 2416-21. https://doi.org/10.1097/01.CCM.0000147769.07699.E3
  5. Kjalke M, Monroe DM, Hoffman M, Oliver JA, Ezban M, Roberts HR. Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation. Thromb Haemost 1998;80:578-84.
  6. Rezaie AR. Regulation of the protein C anticoagulant and antiinflammatory pathways. Curr Med Chem 2010;17:2059-69. https://doi.org/10.2174/092986710791233706
  7. Levin EG, Marzec U, Anderson J, Harker LA. Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. J Clin Invest 1984;74:1988-95. https://doi.org/10.1172/JCI111620
  8. Gelehrter TD and Sznycer-Laszuk R. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. J Clin Invest 1986;77:165-9. https://doi.org/10.1172/JCI112271
  9. Wang W, Boffa MB, Bajzar L, Walker JB, Nesheim ME. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor. J Biol Chem 1998;273:27176-81. https://doi.org/10.1074/jbc.273.42.27176
  10. Satta N, Toti F, Feugeas O, Bohbot A, Dachary-Prigent J, Eschwege V, et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 1994;153: 3245-55.
  11. Taylor FB Jr, Hoogendoorn H, Chang AC, Peer G, Nesheim ME, Catlett R, et al. Anticoagulant and fibrinolytic activities are promoted, not retarded, in vivo after thrombin generation in the presence of a monoclonal antibody that inhibits activation of protein C. Blood 1992;79:1720-8.
  12. Aird WC. Endothelium and haemostasis. Hamostaseologie 2015;35:11-6. https://doi.org/10.5482/HAMO-14-11-0075
  13. Monahan-Earley R, Dvorak AM, Aird WC. Evolutionary origins of the blood vascular system and endothelium. J Thromb Haemost 2013; 11(Sl):46-66. https://doi.org/10.1111/jth.12253
  14. Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 2002;296:1880-2. https://doi.org/10.1126/science.1071699
  15. Abeyama K, Stern DM, Ito Y, Kawahara K, Yoshimoto Y, Tanaka M, et al. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Invest 2005;115:1267-74. https://doi.org/10.1172/JCI22782
  16. Moxon CA, Chisala NV, Mzikamanda R, MacCormick I, Harding S, Downey C, et al. Laboratory evidence of disseminated intravascular coagulation is associated with a fatal outcome in children with cerebral malaria despite an absence of clinically evident thrombosis or bleeding. J Thromb Haemost 2015;13:1653-64. https://doi.org/10.1111/jth.13060
  17. Moxon CA, Wassmer SC, Milner DA Jr, Chisala NV, Taylor TE, Seydel KB, et al. Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African children. Blood 2013;122:842-51. https://doi.org/10.1182/blood-2013-03-490219
  18. Turner L, Lavstsen T, Berger SS, Wang CW, Petersen JE, Avril M, et al. Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature 2013;498:502-5. https://doi.org/10.1038/nature12216
  19. Engelmann B and Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013;13:34-45. https://doi.org/10.1038/nri3345
  20. Esmon CT, Xu J, Lupu F. Innate immunity and coagulation. J Thromb Haemost 2011;9(S1):182-8. https://doi.org/10.1111/j.1538-7836.2011.04323.x
  21. Ito T. PAMPs and DAMPs as triggers for DIC. J Intensive Care 2014; 2:67. https://doi.org/10.1186/s40560-014-0067-y
  22. Conway EM. Reincarnation of ancient links between coagulation and complement. J Thromb Haemost 2015;13(S1):S121-32. https://doi.org/10.1111/jth.12950
  23. Kim JE, Lee N, Gu JY, Yoo HJ, Kim HK. Circulating levels of DNA-histone complex and dsDNA are independent prognostic factors of disseminated intravascular coagulation. Thromb Res 2015;135:1064-9. https://doi.org/10.1016/j.thromres.2015.03.014
  24. Nakahara M, Ito T, Kawahara K, Yamamoto M, Nagasato T, Shrestha B, et al. Recombinant thrombomodulin protects mice against histone-induced lethal thromboembolism. PLoS One 2013;8:e75961. https://doi.org/10.1371/journal.pone.0075961
  25. Abrams ST, Zhang N, Manson J, Liu T, Dart C, Baluwa F, et al. Circulating histones are mediators of trauma-associated lung injury. Am J Respir Crit Care Med 2013;187:160-9. https://doi.org/10.1164/rccm.201206-1037OC
  26. Alhamdi Y, Zi M, Abrams ST, Liu T, Su D, Welters I, et al. Circulating histone concentrations differentially affect the predominance of left or right ventricular dysfunction in critical illness. Crit Care Med 2016;44: e278-88. https://doi.org/10.1097/CCM.0000000000001413
  27. Fuchs TA, Bhandari AA, Wagner DD. Histones induce rapid and profound thrombocytopenia in mice. Blood 2011;118:3708-14. https://doi.org/10.1182/blood-2011-01-332676
  28. Longstaff C, Varjú I, Sótonyi P, Szabó L, Krumrey M, Hoell A, et al. Mechanical stability and fibrinolytic resistance of clots containing fibrin, DNA, and histones. J Biol Chem 2013;288:6946-56. https://doi.org/10.1074/jbc.M112.404301
  29. Martinod K and Wagner DD. Thrombosis: tangled up in NETs. Blood 2014;123:2768-76. https://doi.org/10.1182/blood-2013-10-463646
  30. Yamamichi S, Fujiwara Y, Kikuchi T, Nishitani M, Matsushita Y, Hasumi K. Extracellular histone induces plasma hyaluronan-binding protein (factor VII activating protease) activation in vivo. Biochem Biophys Res Commun 2011;409:483-8. https://doi.org/10.1016/j.bbrc.2011.05.030
  31. Semeraro F, Ammollo CT, Morrissey JH, Dale GL, Friese P, Esmon NL, et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 2011;118:1952-61. https://doi.org/10.1182/blood-2011-03-343061
  32. Ammollo CT, Semeraro F, Xu J, Esmon NL, Esmon CT. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J Thromb Haemost 2011;9:1795-803. https://doi.org/10.1111/j.1538-7836.2011.04422.x
  33. Barranco-Medina S, Pozzi N, Vogt AD, Di Cera E. Histone H4 promotes prothrombin autoactivation. J Biol Chem 2013;288:35749-57. https://doi.org/10.1074/jbc.M113.509786
  34. Alhamdi Y, Abrams ST, Cheng Z, Jing S, Su D, Liu Z, et al. Circulating histones are major mediators of cardiac injury in patients with sepsis. Crit Care Med 2015;43:2094-103. https://doi.org/10.1097/CCM.0000000000001162
  35. Levi M, Toh C, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol 2009;145:24-33. https://doi.org/10.1111/j.1365-2141.2009.07600.x
  36. Toh CH, Hoots WK; SSC on Disseminated Intravascular Coagulation of the ISTH. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost 2007;5:604-6. https://doi.org/10.1111/j.1538-7836.2007.02313.x
  37. Gando S, Saitoh D, Ogura H, Fujishima S, Mayumi T, Araki T, et al. A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis. Crit Care 2013;17:R111. https://doi.org/10.1186/cc12783
  38. Wada H, Gabazza EC, Asakura H, Koike K, Okamoto K, Maruyama I, et al. Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis and of the Japanese Ministry of Health and Welfare for overt DIC. Am J Hematol 2003;74:17-22. https://doi.org/10.1002/ajh.10377
  39. Toh CH and Downey C. Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2005; 16:69-74. https://doi.org/10.1097/00001721-200501000-00011
  40. Kinasewitz GT, Zein JG, Lee GL, Nazir SA, Taylor FB Jr. Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis. Crit Care Med 2005;33:2214-21. https://doi.org/10.1097/01.CCM.0000181296.53204.DE
  41. Dhainaut JF, Shorr AF, Macias WL, Kollef MJ, Levi M, Reinhart K, et al. Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med 2005;33:341-8. https://doi.org/10.1097/01.CCM.0000153520.31562.48
  42. Levi M and Meijers JC. DIC: which laboratory tests are most useful. Blood Rev 2011;25:33-7. https://doi.org/10.1016/j.blre.2010.09.002
  43. Kitchen S, Cartwright I, Woods TA, Jennings I, Preston FE. Lipid composition of seven APTT reagents in relation to heparin sensitivity. Br J Haematol 1999;106:801-8. https://doi.org/10.1046/j.1365-2141.1999.01596.x
  44. Wada H, Thachil J, Di Nisio M, Mathew P, Kurosawa S, Gando S, et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost 2013;11: 761-7. https://doi.org/10.1111/jth.12155
  45. Kim HK, Hong KH, Toh CH; Scientific and Standardization Committee on DIC of The International Society on Thrombosis and Haemostasis. Application of the international normalized ratio in the scoring system for disseminated intravascular coagulation. J Thromb Haemost 2010; 8:1116-8.
  46. Thiele T, Selleng K, Selleng S, Greinacher A, Bakchoul T. Thrombocytopenia in the intensive care unit-diagnostic approach and management. Semin Hematol 2013;50:239-50. https://doi.org/10.1053/j.seminhematol.2013.06.008
  47. Kim SY, Kim JE, Kim HK, Han KS, Toh CH. Accuracy of platelet counting by automated hematologic analyzers in acute leukemia and disseminated intravascular coagulation: potential effects of platelet activation. Am J Clin Pathol 2010;134:634-47. https://doi.org/10.1309/AJCP88JYLRCSRXPP
  48. Yaguchi A, Lobo FL, Vincent JL, Pradier O. Platelet function in sepsis. J Thromb Haemost 2004;2:2096-102. https://doi.org/10.1111/j.1538-7836.2004.01009.x
  49. Hyun J, Kim HK, Kim JE, Lim MG, Jung JS, Park S, et al. Correlation between plasma activity of ADAMTS-13 and coagulopathy, and prognosis in disseminated intravascular coagulation. Thromb Res 2009;124:75-9. https://doi.org/10.1016/j.thromres.2008.11.020
  50. Ono T, Mimuro J, Madoiwa S, Soejima K, Kashiwakura Y, Ishiwata A, et al. Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood 2006;107:528-34. https://doi.org/10.1182/blood-2005-03-1087
  51. Alhamdi Y, Abrams ST, Lane S, Wang G, Toh CH. Histone-associated thrombocytopenia in patients who are critically ill. JAMA 2016;315:817-9. https://doi.org/10.1001/jama.2016.0136
  52. Caudrillier A, Kessenbrock K, Gilliss BM, Nguyen JX, Marques MB, Monestier M, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 2012;122:2661-71. https://doi.org/10.1172/JCI61303
  53. Goel R, Ness PM, Takemoto CM, Krishnamurti L, King KE, Tobian AA. Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality. Blood 2015;125: 1470-6. https://doi.org/10.1182/blood-2014-10-605493
  54. Yu M, Nardella A, Pechet L. Screening tests of disseminated intravascular coagulation: guidelines for rapid and specific laboratory diagnosis. Crit Care Med 2000;28:1777-80. https://doi.org/10.1097/00003246-200006000-00013
  55. Mackie IJ, Kitchen S, Machin SJ, Lowe GD; Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Guidelines on fibrinogen assays. Br J Haematol 2003;121:396-404. https://doi.org/10.1046/j.1365-2141.2003.04256.x
  56. Toh JM, Ken-Dror G, Downey C, Abrams ST. The clinical utility of fibrin-related biomarkers in sepsis. Blood Coagul Fibrinolysis 2013;24:839-43. https://doi.org/10.1097/MBC.0b013e3283646659
  57. Nieuwenhuizen W. A reference material for harmonisation of D-dimer assays. Fibrinogen Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thromb Haemost 1997;77:1031-3.
  58. Dempfle CE, Wurst M, Smolinski M, Lorenz S, Osika A, Olenik D, et al. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score. Thromb Haemost 2004;91:812-8.
  59. Olson JD. D-dimer: An overview of hemostasis and fibrinolysis, assays, and clinical applications. Adv Clin Chem 2015;69:1-46.
  60. Choi Q, Hong KH, Kim JE, Kim HK. Changes in plasma levels of natural anticoagulants in disseminated intravascular coagulation: high prognostic value of antithrombin and protein C in patients with underlying sepsis or severe infection. Ann Lab Med 2014;34:85-91. https://doi.org/10.3343/alm.2014.34.2.85
  61. Koyama K, Madoiwa S, Nunomiya S, Koinuma T, Wada M, Sakata A, et al. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study. Crit Care 2014;18:R13. https://doi.org/10.1186/cc13190
  62. Gando S, Kameue T, Nanzaki S, Nakanishi Y. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost 1996;75:224-8.
  63. Dempfle CE and Borggrefe M. Point of care coagulation tests in critically ill patients. Semin Thromb Hemost 2008;34:445-50. https://doi.org/10.1055/s-0028-1092874
  64. Sivula M, Pettilä V, Niemi TT, Varpula M, Kuitunen AH. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2009;20:419-26. https://doi.org/10.1097/MBC.0b013e32832a76e1
  65. Haase N, Ostrowski SR, Wetterslev J, Lange T, Moller MH, Tousi H, et al. Thromboelastography in patients with severe sepsis: a prospective cohort study. Intensive Care Med 2015;41:77-85. https://doi.org/10.1007/s00134-014-3552-9
  66. Müller MC, Meijers JC, Vroom MB, Juffermans NP. Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systematic review. Crit Care 2014;18:R30. https://doi.org/10.1186/cc13721

Cited by

  1. HUS and atypical HUS vol.129, pp.21, 2017, https://doi.org/10.1182/blood-2016-11-709865
  2. Phosphatidylserine-mediated platelet clearance by endothelium decreases platelet aggregates and procoagulant activity in sepsis vol.7, pp.None, 2016, https://doi.org/10.1038/s41598-017-04773-8
  3. Immunothrombotic Activity of Damage-Associated Molecular Patterns and Extracellular Vesicles in Secondary Organ Failure Induced by Trauma and Sterile Insults vol.9, pp.None, 2016, https://doi.org/10.3389/fimmu.2018.00190
  4. Sepsis-Associated Coagulopathy Severity Predicts Hospital Mortality* vol.46, pp.5, 2018, https://doi.org/10.1097/ccm.0000000000002997
  5. Machine learning-based diagnosis for disseminated intravascular coagulation (DIC): Development, external validation, and comparison to scoring systems vol.13, pp.5, 2018, https://doi.org/10.1371/journal.pone.0195861
  6. Ticagrelor-induced thrombotic thrombocytopenic purpura : A case report and review of the literature vol.97, pp.26, 2018, https://doi.org/10.1097/md.0000000000011206
  7. TTP-like syndrome: novel concept and molecular pathogenesis of endotheliopathy-associated vascular microthrombotic disease vol.16, pp.None, 2016, https://doi.org/10.1186/s12959-018-0174-4
  8. Cooling therapy upregulates protein C activation in heat stressed rats: An experimental study vol.234, pp.8, 2019, https://doi.org/10.1002/jcp.28114
  9. Multiple limb compartment syndrome as a manifestation of capillary leak syndrome secondary to metformin and dipeptidyl peptidase IV inhibitor overdose : A case report vol.99, pp.29, 2016, https://doi.org/10.1097/md.0000000000021202
  10. Physiology of Midkine and Its Potential Pathophysiological Role in COVID-19 vol.11, pp.None, 2016, https://doi.org/10.3389/fphys.2020.616552
  11. Paeoniflorin alleviates lipopolysaccharide‐induced disseminated intravascular coagulation by inhibiting inflammation and coagulation activation vol.81, pp.4, 2020, https://doi.org/10.1002/ddr.21647
  12. Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control? vol.43, pp.7, 2016, https://doi.org/10.2337/dc20-0723
  13. Damage-associated molecular patterns in trauma vol.46, pp.4, 2016, https://doi.org/10.1007/s00068-019-01235-w
  14. Alterations in platelet behavior after major trauma: adaptive or maladaptive? vol.32, pp.3, 2016, https://doi.org/10.1080/09537104.2020.1718633
  15. Hemostatic Disorders: Physiology, Diagnostics, and Management vol.25, pp.4, 2016, https://doi.org/10.1188/21.cjon.379-382
  16. Hypercoagulopathy, acquired coagulation disorders and anticoagulation before, during and after extracorporeal membrane oxygenation in COVID-19: a case series vol.36, pp.6, 2021, https://doi.org/10.1177/02676591211001791
  17. An audit of disseminated intravascular coagulation screen requests at an academic hospital laboratory in central South Africa vol.43, pp.5, 2016, https://doi.org/10.1111/ijlh.13461
  18. Application of the International Society on Thrombosis and Haemostasis Scoring System in Evaluation of Disseminated Intravascular Coagulation in Patients with Acute Leukemias vol.10, pp.4, 2016, https://doi.org/10.1055/s-0041-1733347